Fundraising Fox

YourChoice Therapeutics

YC W19

San Francisco, US · Founded 2018 · 3 employees · 5 known investors

YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production. The company targets men seeking an alternative to condoms or vasectomy.

BiotechHealthtechMedical DevicesHealth TechUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W19)

YourChoice Therapeutics was founded in 2018 by Akash Bakshi and Nadja Mannowetz.

ABAkash Bakshi
Akash BakshiinCo-founder · Chief Executive Officer
NMNadja Mannowetz
Nadja MannowetzinCo-founder & CSO

Investors · 5

Blue Bear VenturesSan Francisco · $100K – $400K
Foreground CapitalBoston
Olive Tree CapitalBoston
PortfoliaSan Mateo · $10K
Y CombinatorSan Francisco · $500K

In the news

YourChoice’s non-hormonal male birth control is safe so farfiercebiotech.com · Jun 2024Male Birth Control Pill Enters Clinical Trialsfstandard.com · Dec 2023YourChoice Therapeutics Begins Landmark Trial for Hormone-Free Male Birth Control Pillfemtechinsider.com · Dec 2023Male birth control pill enters Phase 1 trial in U.K.statnews.com · Dec 2023Male Contraception Company YourChoice Therapeutics Adds $15M in Series A Funding to Kick Off Human Trials | Femtech Insiderfemtechinsider.com · Jul 2022YourChoice Therapeutics raises $15M Series A for male birth controlaxios.com · Jul 2022YourChoice Therapeutics | Goldengolden.comYourChoice Therapeutics 7/21/2022 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does YourChoice Therapeutics do?
YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production. The company targets men seeking an alternative to condoms or vasectomy.
Who founded YourChoice Therapeutics?
YourChoice Therapeutics was founded by Akash Bakshi, Nadja Mannowetz in 2018.
Who are YourChoice Therapeutics's investors?
YourChoice Therapeutics's investors include Blue Bear Ventures, Foreground Capital, Olive Tree Capital, Portfolia, Y Combinator.
Where is YourChoice Therapeutics headquartered?
YourChoice Therapeutics is headquartered in San Francisco, US.